REG - BioPharma Credit PLC - Dividend Declaration

Biopharma CreditAnnouncement

21/03/2024 16:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240321:nRSU8341Ha&default-theme=true

RNS Number : 8341H  BioPharma Credit PLC  21 March 2024

21 March 2024

 

BIOPHARMA CREDIT PLC

("BIOPHARMA CREDIT" OR THE "COMPANY")

DIVIDEND DECLARATION

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor,
is pleased to declare an interim dividend in respect of the financial period
ending 31 March 2024 of $0.0175 per ordinary share, payable on 30 April 2024
to ordinary shareholders on the register as at 2 April 2024. The ex-dividend
date will be 28 March 2024. The Company has chosen to designate the entire
amount of this interim dividend as an interest distribution. Shareholders in
receipt of such a dividend will be treated for UK tax purposes as though they
have received a payment of interest. This will result in a reduction in the
corporation tax payable by the Company.

The Company is currently paying and continues to target a 7 cent annual
dividend per ordinary share.

The default payment for dividends is in US dollars. However, shareholders can
elect to have dividends paid in sterling (GBP) and the option to elect a
sterling dividend payment for this dividend will be available to shareholders
until 2 April 2024 (the "Election Date").

Further details together with a copy of the Dividend Currency Election Form,
which should be sent to Link Group, 10(th) Floor, Central Square, 29
Wellington Street, Leeds LS1 4DL when completed, will be available on the
Group's website shortly at www.bpcruk.com/investor-materials
(http://www.bpcruk.com/investor-materials) . CREST shareholders must elect via
CREST. Further details together with a copy of the Dividend Currency Election
Form, which should be sent to Link Group, 10th Floor, Central Square, 29
Wellington Street, Leeds LS1 4DL when completed, will be available on the
Group's website shortly at www.bpcruk.com/investor-materials
(http://www.bpcruk.com/investor-materials) . CREST shareholders must elect via
CREST.

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0) 333 300 1950

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com (mailto:biopharmacredit@buchanan.uk.com)

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from
the life sciences industry and joined the LSE on 27 March 2017. The Company
seeks to provide long-term shareholder returns, principally in the form of
sustainable income distributions from exposure to the life sciences industry.
The Company seeks to achieve this objective primarily through investments in
debt assets secured by royalties or other cash flows derived from the sales of
approved life sciences products.

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVJBMJTMTTTBJI